Choroidal Structural Changes Assessed with Swept-Source Optical Coherence Tomography after Cataract Surgery in Eyes with Diabetic Retinopathy

Yao, Huiping; Gao, Sha; Liu, Xiaoqing; Zhou, Yufeng; Cheng, Yu; Shen, Xi

doi:https://doi.org/10.1155/2020/5839837

Journal of Ophthalmology

On this page

Abstract Introduction Methods Results Discussion Conclusion Data Availability Conflicts of Interest Authors’ Contributions Acknowledgments Supplementary Materials References Copyright Related Articles

Special Issue

Optical Coherence Tomography Biomarkers and Where to Find Them

View this Special Issue

Research Article | Open Access

Volume 2020 | Article ID 5839837 | https://doi.org/10.1155/2020/5839837

Choroidal Structural Changes Assessed with Swept-Source Optical Coherence Tomography after Cataract Surgery in Eyes with Diabetic Retinopathy

Huiping Yao,^1,2Sha Gao,^1,2Xiaoqing Liu,^1,2Yufeng Zhou,¹Yu Cheng,^1,2and Xi Shen¹

Academic Editor: Marco Nassisi

Received25 Jul 2020

Revised18 Sept 2020

Accepted08 Oct 2020

Published30 Oct 2020

Abstract

Objective. To determine the influence of phacoemulsification on choroidal vasculature in patients with diabetic retinopathy (DR) undergoing cataract surgery using swept-source optical coherence tomography (SS-OCT). Methods. The study was conducted in 23 eyes of 23 cataract patients with mild/moderate nonproliferative diabetic retinopathy (NPDR) without diabetic macular edema (DME) and 23 age-matched controls. Choroidal thickness (CT) and choroidal vascularity index (CVI) were measured at baseline and 1 week, 1 month, and 3 months after surgery. Results. The baseline CVI in the DR group was significantly lower than that in the control group (). CVI in DR patients after surgery significantly increased compared with preoperative values (all for 1 week, 1 month, and 3 months after surgery). Postoperative increase of CVI and CT in the DR group was more than in the control group, and the difference was significant 1 month and 3 months after surgery (all ). Conclusion. Patients with mild/moderate NPDR have reduced CVI compared with nondiabetic patients at baseline; diabetic cataract surgery tended to induce more increase in CVI and CT as compared with nondiabetic patients. This trial is registered with NCT04499768.

1. Introduction

Diabetes is considered to be a risk factor of cataract incidence and development; diabetic patients usually develop cataracts earlier [1]. Cataract extraction using phacoemulsification usually results in remarkable visual acuity outcomes and is one of the most common and safe ophthalmic surgical procedures. However, diabetic cataract surgery sometimes could be complicated by macular edema, and progression of diabetic retinopathy [2, 3], and these complications also lead to poor visual acuity recovery, so the right timing of cataract surgery of diabetic patients should be considered.

The choroid is one region with high blood circulation ratio, predominantly composed of blood vessels and surrounding stromal tissue. Choroid is the major blood supply to the retina, supplying nutrients and oxygen to the retina. Thus, choroid with normal structure and function is important for maintaining normal retinal physiology [4, 5]. Diabetic choroidopathy (DC) was firstly reported by Hidayat and Fine, and it was reported that there existed arteriosclerotic choroidal arteries, luminal narrowing, basement membranes thickening, and choriocapillaris dropout in DC [6]. It was pointed out that DC may play a role in the pathology of DR [6, 7].

With the advent of optical coherence tomography (OCT) technology, choroidal thickness (CT) was widely measured and it was noted that most patients with senile cataract were expected to maintain increased choroid thickness at least for several months after cataract surgery [8–10]. Recently, CVI is used to distinguish lumens of choroidal vasculature from surrounding stroma and has been proposed as a marker for vascular health of choroid [11–15]. Choroidal vasculature might be involved in the diabetic eyes and change with duration of diabetes, and a reduced CVI has been recently noted in DR [13, 16]. But the influence of the cataract surgery on the choroidal vascular structures in DR patients is not clear.

The new generation swept-source optical coherence tomography (SS-OCT) system penetrates deeper into the tissue and provides high-resolution images, so it is thought to have advantages for the assessment of the choroid [17, 18]. In this study, we aimed to determine the influence of phacoemulsification on choroidal vascular structures in patients with DR undergoing cataract surgery through the follow-up values of CT and CVI using this SS-OCT system.

2. Methods

2.1. Study Subjects

This study included 23 eyes of 23 cataract patients with mild/moderate NPDR without DME, and 23 age-matched nondiabetic patients were also enrolled in this study. All individuals underwent comprehensive ophthalmologic examination, including a dilated fundal examination, measurements of IOP, best-corrected visual acuity (BCVA), axial length (AL), and SS-OCT. IOP was measured using noncontact tonometry (TX-20, Canon, Japan) at all visits; BCVA was measured using a standard logarithmic visual acuity chart to calculate the logarithm of reciprocal decimal visual acuity (logMAR VA) at baseline and 3 months after surgery; AL was measured using ocular biometry (LenStar LS-900, Haag-Streit AG, Switzerland) at baseline; and SS-OCT was measured at all visits. The stage of NPDR was graded based on the international clinical disease severity scale for DR [19]. All cataract patients undergoing uncomplicated phacoemulsification surgery were recruited consecutively (from June 2018 to June 2019) from the Ophthalmology Department of Ruijin Hospital North and signed the consent forms. The study was adhered to the provisions of the Declaration of Helsinki and was approved by the Ethical Review Committee of Ruijin Hospital North. If both eyes of one patient were operated, only the eye which was operated on first was enrolled.

The inclusion criteria were as follows: aged >40 years, intraocular pressure (IOP) < 21 mmHg in both eyes, and spherical refractive error <6 diopters spherical equivalent. The exclusion criteria were as follows: previous retinal surgery, glaucoma, uveitis, age-related macular degeneration, arterial or vein occlusions, macular hole, or other ocular diseases that could interfere the CT and/or CVI measurement, severe systemic diseases, such as leukemia, rheumatic disease, malignant tumors, uncontrolled hypertension, obstructive sleep apnea, etc., and decreased media transparency precluding appropriate OCT imaging.

2.2. Cataract Surgery

The phacoemulsification cataract surgeries were performed by the same skilled surgeon using the Infinity Vision System (Alcon Laboratories, Inc.). None of the patients had operative complications. All patients had hydrophilic acrylic intraocular lens (Softec HD, Lenstec, Inc. USA) implanted into their capsular bags and had one month of topical steroids. The cumulative dissipated energy (CDE) was documented. Postoperative treatment consisted of tobramycin dexamethasone eyedrops administered 4 times a day for 1 week and then prednisolone acetate 1.0% and levofloxacin 0.5% eyedrops administered 3 times a day for 3 weeks.

2.3. SS-OCT Data Acquisition

All study subjects were imaged using the SS-OCT (Triton DRI-OCT, Topcon, Inc, Tokyo, Japan) preoperatively and at 1 week (W1), 1 month (M1), and 3 months (M3) postoperatively, and the OCT scans were tracked at all follow-up visits. All images were acquired in the morning considering the diurnal variation of choroid vasculature. Images with a signal strength index of more than 40 and no residual motion artifacts were saved for further analysis. CT was defined as the distance between the outer boundary of retinal pigment epithelium/Bruch’s membrane and the chorioscleral interface, and the CT values were obtained with the built-in software of the SS-OCT device (Topcon FastMap, version 10.13.003.06). The foveal CT was defined as the CT value in the center circle in the standard ETDRS grid; the parafoveal CT was defined as the arithmetic average value of CT in subregions in the annulus with an outer diameter of 3.0 mm and an inner diameter of 1.0 mm in the standard ETDRS grid; the perifoveal CT was defined as the arithmetic average value of CT in subregions in the annulus with an outer diameter of 6.0 mm and an inner diameter of 3.0 mm in the standard ETDRS grid.

2.4. Procedures of Image Binarization

CVI was acquired through the method described as follows. Images were analyzed by one public domain software, Image J (version 1.52a, provided in the public domain by the National Institutes of Health, Bethesda, MD, USA; http://imagej.nih.gov/ij/), using the protocol as previously described with modifications [11, 12, 20]. Briefly, 9 mm scan images passing through the fovea horizontally were chosen. The region of interest (ROI) was manually selected using the polygon tool and added to the ROI manager. The images were adjusted by the Niblack auto local threshold. The binarized image was converted to the RGB image, and the luminal area was determined using the threshold tool. The dark pixels represented the luminal or vascular area, and the light pixels were defined as stromal or interstitial area (Figure 1). CVI was defined as the proportion of vascular area to total circumscribed area.

(a)

(b)

(c)

(d)

2.5. Inter-Rater and Intra-Rater Agreement

Two independent graders masked from patient information initially segmented 46 images from all the subjects. The same images were segmented by one of the above two graders after an interval of one week to determine intra-rater reliability. The inter-rater reliability and intra-rater reliability for image binarization were indicated by the absolute agreement model of the intraclass correlation coefficient (ICC), performed using IBM SPSS statistics version 21.0. The ICC value of 0.81–1.00 indicates good agreement.

2.6. Statistical Analysis

Statistical analyses were performed using GraphPad Prism 7.0 (GraphPad Software, CA). Normally distributed data were expressed as mean ± standard deviation (SD). The preoperative and postoperative measurements were compared by the paired t-test. The difference between two groups was compared by the unpaired t-test. Pearson correlation analyses were performed to determine the relationships between CVI/CT and related factors. was considered to be statistically significant.

3. Results

A total of 46 eyes of 46 subjects were recruited in the study; the DR group included 23 mild/moderate NPDR patients (12 males and 11 females) and the control group included 23 nondiabetic patients (13 males and 10 females). Table 1 shows patients’ demographic and clinical characteristics, and the DR group included 14 moderate NPDR patients and 9 mild NPDR patients; 3 patients had coronary heart disease and 7 patients had well-controlled hypertension in the DR group. There was no significant difference in age, gender, BCVA, IOP, AL, or CDE between the DR group and the control group.

After the cataract surgery, the BCVA was significantly improved and IOP significantly decreased. The baseline IOP in DR and control groups was 16.1 ± 0.6 mmHg and 15.6 ± 0.6 mmHg, respectively. After surgery, the IOP of the control group significantly decreased (, <0.001, and <0.001 for 1 week, 1 month, and 3 months after surgery compared with the preoperative values). After surgery, the IOP of the DR group also significantly decreased (, <0.001, and <0.001 for 1 week, 1 month, and 3 months after surgery compared with the preoperative values).

3.1. Inter-Rater and Intra-Rater Agreement for CVI

The inter-rater agreement for CVI was 0.932 (95% confidence interval (CI): 0.877–0.962) for average measure and 0.872 (95% CI: 0.781–0.927) for single measure; the intra-rater agreement for CVI was 0.951 (95% CI: 0.911–0.973) for average measure and 0.906 (95% CI: 0.837–0.947) for single measure. These ICC values above indicated a significantly high agreement for the image segment.

3.2. CVI

The baseline CVI in the DR group was significantly lower than that in the control group; there was a significant difference between the two groups (mean difference = 2.00% and 95% CI: 0.94%–3.07%). After surgery, the CVI of the control group was significantly increased at 1 month and 3 months postoperatively. The CVI of the DR group significantly increased at 1 week, 1 month, and 3 months postoperatively (Table 2 and Figure 2). CVI at any visit did not correlate with age, AL, CDE, or IOP in the DR group and control group (Supplementary Table 1).

After surgery, increase of CVI in DR group was more than that in the control group, and the difference was significant at 1 month and 3 months after surgery (mean difference = 1.57%; 95% CI: 0.04–3.09% for 1 month after surgery; mean difference = 1.29%; 95% CI: 0.12%–2.46% for 3 months after surgery) (Table 3 and Figure 3).

(a)

(b)

(c)

(d)

3.3. CT

The baseline CT of the fovea, parafovea, and perifovea of the DR group was not significantly thinner than that of the control group (, 0.254, and 0.133 for fovea, parafovea, and perifovea, respectively).

A significant increase in CT was found after surgery in the DR group. The CT of the DR group significantly increased at 1 week, 1 month, and 3 months postoperatively in all regions (Figure 4 and Table 4).

(a)

(b)

In the control group, CT was found to increase in some parts of the macula. The CT of fovea at 3 months postoperatively, the CT of parafovea at 1 week, 1 month and 3 months postoperatively, and the CT of perifovea at 1 month and 3 months postoperatively were found significantly thicker than the baseline CT (Figure 4 and Table 4). CT did not correlate with AL, CDE, or IOP at any region in the control group and DR group (Supplementary Tables 2 and 3).

After surgery, increase of CT in the DR group was more than that in the control group, 1 month, and 3 months after surgery in all regions of macula (Table 3 and Figure 3). The difference between the two groups was significant for 1 month and 3 months after surgery at fovea (mean difference = 15.86; 95% CI: 3.46–28.26 for 1 month after surgery; mean difference = 12.39; 95% CI: 3.77–21.01 for 3 months after surgery); the difference was also significant for 1 month and 3 months after surgery at parafovea (mean difference = 11.33; 95% CI: 1.81–20.84 for 1 month after surgery; mean difference = 10.22; 95% CI: 2.42–18.02 for 3 months after surgery) and was significant for 1 month and 3 months after surgery at perifovea (mean difference = 11.1; 95% CI: 2.57–19.62 for 1 month after surgery; mean difference = 9.17; 95% CI: 1.34–17.01 for 3 months after surgery).

4. Discussion

Cataract extraction has been identified as a risk factor for DR progression [21, 22]. However, less DR progression was reported in patients undergoing phacoemulsification as compared with intracapsular cataract extraction and extracapsular cataract extraction [23], and Squirrell et al. even concluded that uncomplicated phacoemulsification cataract surgery does not cause acceleration of diabetic retinopathy postoperatively [24]. There seems to exist some controversies.

In the present study, we focused on quantitatively evaluating changes of the choroidal structures through SS-OCT-based CT and CVI measurements in patients with DR and controls undergoing phacoemulsification, aiming to make clear the possible influence of cataract surgery on changes of choroidal structure in patients with DR, which might play an important role in the pathogenesis of DR.

CVI has been found to be a relatively stable index to monitor the progression of choroidal diseases [13, 25, 26] and provide us more information on the proportion of vascularity in the choroid [11]. The significantly low CVI might reflect the narrowing and/or closure of choroidal vessels. In this study, baseline CVI was found to be significantly lower in patients with mild/moderate NPDR as compared with the controls, which seemed to be a hint of the existence of diabetic vasculopathy in DR patients, despite the result that no significant difference had been found between DR patients and controls in the baseline CT in this study. These results were similar to the previous studies [13, 16]. Tan et al. have reported a significantly lower CVI in diabetic patients with DR and without DR as compared with controls, but they found no significant differences in the CT between patients with DM and controls [13]. CVI seems to provide us more information on diabetic vasculopathy in DR and be more sensitive in monitoring the changes of choroidal vascularity in DR.

The influence of surgery on the choroidal structure is uncertain in the diabetics in previous studies. A number of publications have reported that phacoemulsification may cause a significant increase in choroid thickness [27–29]. However, some studies found no CT variation after cataract surgery in diabetics [30, 31].

In our study, CVI of the patients with mild/moderate NPDR was found to increase significantly at all visits after surgery; in contrast, the CVI of the control group had no significant increase 1 week after surgery, but it was found to increase 1 month and 3 months after surgery; therefore, the increase of CVI seemed to occur earlier in the patients with mild/moderate NPDR than in the controls. In addition, we also found that the variation in CVI and CT before and after surgery in patients with mild/moderate NPDR was more than that in the controls 1 month and 3 months after surgery. Obviously, for the first time, our present study showed that diabetic cataract surgery tended to induce more increase in the CVI and CT as compared with the controls. All the results above implied that cataract surgery seemed to have more influence on the choroidal vascularity in mild/moderate DR patients than in nondiabetic patients.

It has been experimentally verified that cataract surgery induces the expression of some proinflammatory cytokine in the choroid; it was detected that IL-1β and CCL2 gene expression and protein expression were upregulated in the choroid [32]. In addition, the upregulation of vascular endothelial growth factor (VEGF) was observed in the diabetic choroid, and VEGF may contribute to increased vascular permeability and angiogenesis during retinopathy [33]. The high levels of proinflammatory cytokines and VEGF in the preoperative choroid of patients with DR may be one of the underlying mechanisms of the upregulating expression postoperatively, which is likely to induce more increase in CT and CVI in mild/moderate NPDR patients than in nondiabetic patients.

In addition, the increased ocular perfusion pressure caused by reduced IOP may induce increased CT in the early period after phacoemulsification [28]. In our study, the IOP of patients with mild/moderate NPDR and controls both significantly decreased after surgery and no significant difference existed between the two groups. The reduced IOP might not be one of the underlying causes of the difference in the variation of CT and CVI following cataract surgery between the patients with mild/moderate NPDR and nondiabetic patients.

One limitation of our study is the relatively small sample size, but the individuals enrolled in had homogeneous ethnicity and similar gender distribution, which reduced some confounding effects. Another limitation is that the follow-up time is short, so the long period influence on choroid could not be observed in this study. A long-time follow-up should be needed in future studies to make clear how long the increase in CVI and CT following cataract surgery would last. Therefore, a large population sample with a longer follow-up should be recommended in future studies.

5. Conclusion

For the first time, the present study showed that cataract surgery tended to induce more increase of CVI and CT in patients with mild/moderate NPDR as compared with nondiabetic patients. Therefore, the cataract surgery seemed to have more influence on the choroid vasculature in DR patients than in nondiabetic patients, which might imply the underlying impact of cataract surgery on the progression of the choroidopathy in DR patients. Meanwhile, baseline CVI was found to be significantly lower in DR patients as compared with the nondiabetic patients. Therefore, CVI could be reckoned as a biomarker for vascular health of choroid in DR patients and might have the potential to be a predictor of progression of DC following cataract surgery. Furthermore, whether changes of CVI and/or CT could be the predictors of progression of DR following cataract surgery at subclinical stages should be focused on in future studies.

Data Availability

All the relevant data of this study are available from the corresponding author upon request.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Authors’ Contributions

Huiping Yao and Sha Gao contributed equally to the work.

Acknowledgments

This work was supported by a grant from the Shanghai Health Commission (grant no. 201940454).

Supplementary Materials

Supplementary Table 1: correlations of CVI with AL, CDE, and IOP for patients with mild/moderate NPDR (DR) and nondiabetic patients (control) at four visits. Supplementary Table 2: correlations of CT with AL, CDE, and IOP for patients with mild/moderate NPDR at four visits in fovea, parafovea, and perifovea. Supplementary Table 3: correlations of CT with AL, CDE, and IOP for nondiabetic patients at four visits in fovea, parafovea, and perifovea. (Supplementary Materials)

References

B. E. K. Klein, R. Klein, and K. E. Lee, “Diabetes, cardiovascular disease, selected cardiovascular disease risk factors, and the 5-year incidence of age-related cataract and progression of lens opacities: the Beaver dam eye study,” American Journal of Ophthalmology, vol. 126, no. 6, pp. 782–790, 1998.
View at: Publisher Site | Google Scholar
I. A. Cunliffe, D. W. Flanagan, N. D. George, R. J. Aggarwaal, and A. T. Moore, “Extracapsular cataract surgery with lens implantation in diabetics with and without proliferative retinopathy,” British Journal of Ophthalmology, vol. 75, no. 1, pp. 9–12, 1991.
View at: Publisher Site | Google Scholar
H. Schatz, D. Atienza, H. R. McDonald, and R. N. Johnson, “Severe diabetic retinopathy after cataract surgery,” American Journal of Ophthalmology, vol. 117, no. 3, pp. 314–321, 1994.
View at: Publisher Site | Google Scholar
A. Campos, E. J. Campos, J. Martins, A. F. Ambrósio, and R. Silva, “Viewing the choroid: where we stand, challenges and contradictions in diabetic retinopathy and diabetic macular oedema,” Acta Ophthalmologica, vol. 95, no. 5, pp. 446–459, 2017.
View at: Publisher Site | Google Scholar
D. L. Nickla and J. Wallman, “The multifunctional choroid,” Progress in Retinal and Eye Research, vol. 29, no. 2, pp. 144–168, 2010.
View at: Publisher Site | Google Scholar
A. A. Hidayat and B. S. Fine, “Diabetic choroidopathy,” Ophthalmology, vol. 92, no. 4, pp. 512–522, 1985.
View at: Publisher Site | Google Scholar
G. A. Lutty, “Diabetic choroidopathy,” Vision Research, vol. 139, pp. 161–167, 2017.
View at: Publisher Site | Google Scholar
A. Pierru, M. Carles, P. Gastaud, and S. Baillif, “Measurement of subfoveal choroidal thickness after cataract surgery in enhanced depth imaging optical coherence tomography,” Investigative Opthalmology & Visual Science, vol. 55, no. 8, pp. 4967–4974, 2014.
View at: Publisher Site | Google Scholar
R. Shahzad, M. A. R. Siddiqui, S. Zafar, F. Kausar, and M. H. Shahzad, “Choroidal thickness changes following cataract surgery using swept source optical coherence tomography,” Canadian Journal of Ophthalmology, vol. 53, no. 1, pp. 60–64, 2018.
View at: Publisher Site | Google Scholar
H. Jiang, Z. Li, R. Sun, D. Liu, and N. Liu, “Subfoveal choroidal and macular thickness changes after phacoemulsification using enhanced depth imaging optical coherence tomography,” Ophthalmic Research, vol. 60, no. 4, pp. 243–249, 2018.
View at: Publisher Site | Google Scholar
R. Agrawal, P. Gupta, K. A. Tan, C. M. Cheung, T. Y. Wong, and C. Y. Cheng, “Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a population-based study,” Scientific Reports, vol. 6, 2016.
View at: Publisher Site | Google Scholar
R. Agrawal, M. Salman, K. A. Tan et al., “Choroidal vascularity index (CVI)--A novel optical coherence tomography parameter for monitoring patients with panuveitis?” PLoS One, vol. 11, 2016.
View at: Publisher Site | Google Scholar
K.-A. Tan, A. Laude, V. Yip, E. Loo, E. P. Wong, and R. Agrawal, “Choroidal vascularity index - a novel optical coherence tomography parameter for disease monitoring in diabetes mellitus?” Acta Ophthalmologica, vol. 94, no. 7, pp. e612–e616, 2016.
View at: Publisher Site | Google Scholar
R. Agrawal, J. Ding, P. Sen et al., “Exploring choroidal angioarchitecture in health and disease using choroidal vascularity index,” Progress in Retinal and Eye Research, vol. 77, 2020.
View at: Publisher Site | Google Scholar
C. Iovino, M. Pellegrini, F. Bernabei et al., “Choroidal vascularity index: an in-depth analysis of this novel optical coherence tomography parameter,” Journal of Clinical Medicine, vol. 9, 2020.
View at: Publisher Site | Google Scholar
H. Endo, S. Kase, Y. Ito et al., “Relationship between choroidal structure and duration of diabetes,” Graefe’s Archive for Clinical and Experimental Ophthalmology, vol. 257, no. 6, pp. 1133–1140, 2019.
View at: Publisher Site | Google Scholar
A. Miki, Y. Ikuno, Y. Jo, and K. Nishida, “Comparison of enhanced depth imaging and high-penetration optical coherence tomography for imaging deep optic nerve head and parapapillary structures,” Clinical Ophthalmology, vol. 7, pp. 1995–2001, 2013.
View at: Publisher Site | Google Scholar
H.-Y. L. Park, H.-Y. Shin, and C. K. Park, “Imaging the posterior segment of the eye using swept-source optical coherence tomography in myopic glaucoma eyes: comparison with enhanced-depth imaging,” American Journal of Ophthalmology, vol. 157, no. 3, pp. 550–557, 2014.
View at: Publisher Site | Google Scholar
C. P. Wilkinson, F. L. Ferris, R. E. Klein et al., “Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales,” Ophthalmology, vol. 110, no. 9, pp. 1677–1682, 2003.
View at: Publisher Site | Google Scholar
H. Chen, Z. Wu, Y. Chen, M. He, and J. Wang, “Short-term changes of choroidal vascular structures after phacoemulsification surgery,” BMC Ophthalmology, vol. 18, 2018.
View at: Publisher Site | Google Scholar
J. J. Alpar, “Cataract extraction and diabetic retinopathy,” American Intra-ocular Implant Society Journal, vol. 10, no. 4, pp. 433–437, 1984.
View at: Publisher Site | Google Scholar
G. J. Jaffe and T. C. Burton, “Progression of nonproliferative diabetic retinopathy following cataract extraction,” Archives of Ophthalmology, vol. 106, no. 6, pp. 745–749, 1988.
View at: Publisher Site | Google Scholar
T. Hong, P. Mitchell, T. de Loryn, E. Rochtchina, S. Cugati, and J. J. Wang, “Development and progression of diabetic retinopathy 12 months after phacoemulsification cataract surgery,” Ophthalmology, vol. 116, no. 8, pp. 1510–1514, 2009.
View at: Publisher Site | Google Scholar
D. Squirrell, R. Bhola, J. Bush, S. Winder, and J. F. Talbot, “A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes,” British Journal of Ophthalmology, vol. 86, no. 5, pp. 565–571, 2002.
View at: Publisher Site | Google Scholar
L. H. L. Koh, R. Agrawal, N. Khandelwal, L. Sai Charan, and J. Chhablani, “Choroidal vascular changes in age-related macular degeneration,” Acta Ophthalmologica, vol. 95, no. 7, pp. e597–e601, 2017.
View at: Publisher Site | Google Scholar
W. Y. Ng, D. S. W. Ting, R. Agrawal et al., “Choroidal structural changes in myopic choroidal neovascularization after treatment with antivascular endothelial growth factor over 1 year,” Investigative Opthalmology & Visual Science, vol. 57, no. 11, pp. 4933–4939, 2016.
View at: Publisher Site | Google Scholar
S. A. Bayhan, H. A. Bayhan, E. Muhafiz, K. Kırboğa, and C. Gurdal, “Evaluation of choroidal thickness changes after phacoemulsification surgery,” Clinical Ophthalmology, vol. 10, pp. 961–967, 2016.
View at: Publisher Site | Google Scholar
H. Ohsugi, Y. Ikuno, Z. Ohara et al., “Changes in choroidal thickness after cataract surgery,” Journal of Cataract & Refractive Surgery, vol. 40, no. 2, pp. 184–191, 2014.
View at: Publisher Site | Google Scholar
T. Yilmaz, A. A. Karci, I. Yilmaz et al., “Long-Term changes in subfoveal choroidal thickness after cataract surgery,” Medical Science Monitor, vol. 22, pp. 1566–1570, 2016.
View at: Google Scholar
P. N. Brito, V. M. Rosas, L. M. Coentrão et al., “Evaluation of visual acuity, macular status, and subfoveal choroidal thickness changes after cataract surgery in eyes with diabetic retinopathy,” Retina, vol. 35, no. 2, pp. 294–302, 2015.
View at: Publisher Site | Google Scholar
V. C.-H. Yip, A. Laude, K. A. Tan, J. Ding, E. Wong, and R. Agrawal, “A longitudinal study of choroidal changes following cataract surgery in patients with diabetes,” Diabetes and Vascular Disease Research, vol. 16, no. 4, pp. 369–377, 2019.
View at: Publisher Site | Google Scholar
H. Xu, M. Chen, J. V. Forrester, and N. Lois, “Cataract surgery induces retinal pro-inflammatory gene expression and protein secretion,” Investigative Opthalmology & Visual Science, vol. 52, no. 1, pp. 249–255, 2011.
View at: Publisher Site | Google Scholar
G. A. Lutty, D. S. McLeod, C. Merges, A. Diggs, and J. Plouet, “Localization of vascular endothelial growth factor in human retina and choroid,” Archives of Ophthalmology, vol. 114, no. 8, pp. 971–977, 1996.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2020 Huiping Yao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

675

Downloads

654

Citations